The Michigan Medicine Non-Alcoholic Fatty Liver Disease Clinic (NAFLD) is a specialty clinic focused on the care of patients with NAFLD and Non-alcoholic steatohepatitis (NASH).
The Michigan Medicine NAFLD Clinic is a specialty clinic focused on the care of patients with NAFLD and Non-alcoholic steatohepatitis (NASH) including those with cirrhosis from NAFLD and NASH. This multidisciplinary clinic consists of liver disease physicians, advanced practitioners and GI nutritionists specializing in the care of this unique patient population. The Michigan Medicine NAFLD clinic provides a comprehensive diagnostic evaluation, assessment of disease severity and individualized treatment plans for patients. Additionally, we are committed to advancing knowledge and improving patient care through research. Patients in this clinic have the opportunity to participate in a variety of cutting-edge research studies including new pharmacologic therapies. Held in the Taubman Center at the University Hospital in Ann Arbor.
Monica Konerman, MD, MSc
Founder and Director of the Michigan Medicine NAFLD Clinic. Dr Konerman cares for patients with all forms of liver disease including evaluation and management of patients in need liver transplant, but specializes in the diagnosis and management of patients with NAFLD.
Hari Conjeevaram, MD
Co-Director of the Michigan Medicine NAFLD Clinic and the GI fellowship Program Director at the University of Michigan.
Hellan Kwon, MD
Associate-Director of the Michigan Medicine NAFLD Clinic.
The exact reason why some patients develop NAFLD while others with similar risk factors do not is unknown. Similarly, there is not an accurate way to predict why some patients develop advanced disease. Research is critical to add to our understanding of NAFLD and improve treatment and management for patients. There are multiple studies ongoing at Michigan Medicine related to NAFLD and NASH. To find actively recruiting research studies, please visit the NAFLD page under Clinical Studies.